Identification of high-quality cancer prognostic markers and metastasis network modules
Open Access
- 13 July 2010
- journal article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 1 (1), 34-8
- https://doi.org/10.1038/ncomms1033
Abstract
There has been great interest in attempting to identify gene expression signatures that predict cancer survival. In this study a new algorithm is developed to analyse gene expression datasets that accurately classify both ER+ and ER− breast cancers into low- and high-risk groups.Keywords
This publication has 25 references indexed in Scilit:
- Gene-Expression Signatures in Breast CancerNew England Journal of Medicine, 2009
- Genetic studies of diseasesCellular and Molecular Life Sciences, 2007
- A map of human cancer signalingMolecular Systems Biology, 2007
- Network‐based classification of breast cancer metastasisMolecular Systems Biology, 2007
- Concordance among Gene-Expression–Based Predictors for Breast CancerNew England Journal of Medicine, 2006
- An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survivalProceedings of the National Academy of Sciences of the United States of America, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998